Oruka Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Oruka Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q4 2024.
  • Oruka Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 16.8M shares, a 16.5% increase year-over-year.
  • Oruka Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 16.8M shares, a 16.5% increase from 2023.
  • Oruka Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 14.4M shares, a 0.04% increase from 2022.
  • Oruka Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 14.4M shares, a 3.64% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 16.8M +2.37M +16.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 15M +604K +4.19% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 14.5M +96.7K +0.67% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 14.5M +91K +0.63% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 14.4M +5.73K +0.04% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-01
Q3 2023 14.4M 0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-18
Q2 2023 14.4M 0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 14.4M 0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 14.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-01
Q3 2022 14.4M 0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 14.4M 0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-21
Q1 2022 14.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-24
Q3 2021 14.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 14.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q4 2014 20.5M +11.9M +138% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-19
Q3 2014 21M +10.2M +94.1% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q2 2014 21M +16.1M +325% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-13
Q1 2014 18.8M +15.7M +518% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-13
Q4 2013 8.63M +6.41M +288% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-19
Q3 2013 10.8M +8.55M +374% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 4.95M +2.92M +144% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 3.04M +1.01M +49.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 2.23M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 2.29M -8.23M -78.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 2.03M -8.1M -80% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 2.03M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q3 2011 10.5M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 10.1M +1.4M +16% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q2 2010 8.73M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.